RobertGregoryBociekMD

Oncology • Omaha, NE

Associate Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine

Join to view full profile

Dr. Bociek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bociek's full profile

Already have an account?

Office
111 N 175th St
Omaha, NE 68118
Phone+1 402-596-3100

Fax+1 402-552-2512

Education & Training

University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1994
University of Ottawa Faculty of MedicineClass of 1988

Certifications & Licensure

NE State Medical License 1998 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2002 May 08
Completed
Phase 2
CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma Start of enrollment: 2001 May 23
Completed
Not Applicable
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Start of enrollment: 2008 Jan 15
Completed
Phase 2
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer Start of enrollment: 2008 Sep 01
Withdrawn
Phase 1, Phase 2
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2009 Oct 01
Completed
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer Start of enrollment: 2009 Dec 10
Terminated
Phase 2
Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma Start of enrollment: 2013 Jun 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North Am...
Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart
Journal of Hematology & Oncology. 2023-12-16
13 citations
Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?
Prajwal Dhakal, Christopher S. Wichman, Bunny Pozehl, Meaghann S. Weaver, Alfred L. Fisher
Future Oncology. 2021-11-11
1 citations
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Mridula Krishnan, R. Gregory Bociek, Michelle A. Fanale, Swaminathan P. Iyer, Mary Jo Lechowicz
Annals of Hematology. 2021-10-20